These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30407752)

  • 1. Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.
    Horwitz DA; Bickerton S; Koss M; Fahmy TM; La Cava A
    Arthritis Rheumatol; 2019 Apr; 71(4):632-640. PubMed ID: 30407752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice
    Horwitz DA; Liu A; Bickerton S; Castaldo G; Matarese G; Fahmy TM; La Cava A
    Front Immunol; 2020; 11():583338. PubMed ID: 33391260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
    Giang S; Horwitz DA; Bickerton S; La Cava A
    Front Immunol; 2021; 12():628059. PubMed ID: 34122401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
    Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
    Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
    Sharabi A; Mozes E
    J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease.
    Heiler S; Lötscher J; Kreuzaler M; Rolink J; Rolink A
    Front Immunol; 2018; 9():656. PubMed ID: 29670626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.
    Singh RP; La Cava A; Wong M; Ebling F; Hahn BH
    J Immunol; 2007 Jun; 178(12):7649-57. PubMed ID: 17548601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8
    Kato H; Perl A
    Front Immunol; 2021; 12():635531. PubMed ID: 33763079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
    Lavi Arab F; Rastin M; Faraji F; Zamani Taghizadeh Rabe S; Tabasi N; Khazaee M; Haghmorad D; Mahmoudi M
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):12-8. PubMed ID: 25318538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).
    Datta SK
    Front Immunol; 2021; 12():629807. PubMed ID: 33936042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.
    Zhang L; Bertucci AM; Ramsey-Goldman R; Harsha-Strong ER; Burt RK; Datta SK
    Clin Immunol; 2013 Dec; 149(3):365-78. PubMed ID: 24211843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome.
    Zheng SG; Wang JH; Koss MN; Quismorio F; Gray JD; Horwitz DA
    J Immunol; 2004 Feb; 172(3):1531-9. PubMed ID: 14734731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.
    von Spee-Mayer C; Siegert E; Abdirama D; Rose A; Klaus A; Alexander T; Enghard P; Sawitzki B; Hiepe F; Radbruch A; Burmester GR; Riemekasten G; Humrich JY
    Ann Rheum Dis; 2016 Jul; 75(7):1407-15. PubMed ID: 26324847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
    Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
    J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.
    Notley CA; McCann FE; Inglis JJ; Williams RO
    Arthritis Rheum; 2010 Jan; 62(1):171-8. PubMed ID: 20039431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis.
    Fischer R; Proske M; Duffey M; Stangl H; Martinez GF; Peters N; Kraske A; Straub RH; Bethea JR; Kontermann RE; Pfizenmaier K
    Arthritis Rheumatol; 2018 May; 70(5):722-735. PubMed ID: 29342501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.